Statement: Zantac (ranitidine) litigation – Kasza case
Issued: London, UK
For media and investors only
Download
(PDF, 137.8KB)
GSK plc (LSE/NYSE: GSK) welcomes the plaintiff’s voluntary dismissal of the next Zantac case (Kasza), which was scheduled to start trial in Illinois state court on 10 June...
Zur Pressemeldung auf www.gsk.com